July 3, 2008   Sweden
Protein Sciences shareholders meeting was postponed due to a variety of reasons including that notice of the meeting was not adequate.
The company Emergent BioSolutions has announced a bid on Protein Sciences, a company of which Diamyd Medical owns 6,7% of the shares. The 23rd of June 2008 the proposal was supposed to be put up for approval for the shareholders in Protein Sciences. However, the shareholders meeting was postponed due to a variety of reasons, including that notice of the meeting was not adequate.

Read Bloomberg-article here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS